Cancer Therapy Efficacy may Be Improved by Drug Combo

A new study has indicated that combination of drugs inhibiting receptor tyrosine kinases (RTKs)and targeting inhibitors of apoptosis (IAP) may improve cancer therapy efficacy.

Previous studies have shown that therapeutics targeting RTKs would likely be beneficial to individuals with glioblastoma multiforme (GBM), one of the most aggressive types of brain tumour.

About Brain Tumor
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.

However, a small proportion of patients respond to such treatment and most subsequently relapse after only a short time.

During the study, human GBM cells were exposed in vitro to an inhibitor of the RTK PDGFR, which in turn activated a cellular pathway that usually induces cells to undergo a form of cell death known as apoptosis, but the final steps of the pathway were not completed, meaning that the cells did not die.

The team found that final steps of this pathway were blocked by a group of proteins known as IAPs.

Human Skin Protein Attacked By Mobile Phone Radiations
Mobile phone users have been frequently cautioned about the possible ill effects its radiations could bring to their health.

The study suggested that if the PDGFR inhibitor was combined with an IAP inhibitor the GBM cells underwent apoptosis.

Further, this drug combination showed enhanced efficacy at stalling tumour growth in an orthotopic mouse model of GBM.

Genetic Mapping Could Help for Better Diagnosis, Treatment of Common Tumors
Researches have developed a genetic mapping tool which could allow for better diagnosis and treatment of common tumors, according to a study published Monday.

The authors revealed that combining drugs targeting IAPs with RTK inhibitors might prove beneficial to individuals with GBM.

Source-ANI
RAS/L

Childhood Strokes Linked to Whiplash, Other Traumatic Injury
Strokes in children may occur even more often than brain tumors but unlike cancer, sadly, strokes in children are sometimes not recognized and treated, or at least not as early as they should be.